Induction of antibody-dependent and nonspecific tumor killing in human monocytic leukemia cells by nonlymphocyte factors and phorbol ester.
D000920:Antibody-Dependent Cell Cytotoxicity / Q000187:drug effects; D002460:Cell Line; D006801:Humans; D007938:Leukemia / Q000276:immunology*; D007951:Leukemia, Myeloid / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000276:immunology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology; D010587:Phagocytosis; D010704:Phorbols / Q000494:pharmacology*; D011951:Receptors, Complement / Q000032:analysis; D011961:Receptors, Fc / Q000032:analysis; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*; D001749:Urinary Bladder Neoplasms / Q000276:immunology
D010704:Phorbols; D011951:Receptors, Complement; D011961:Receptors, Fc; D013755:Tetradecanoylphorbol Acetate